Clinical Trial Update: Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating maraviroc in combination with darunavir/ritonavir in treatment-naïve HIV-1 patients with R5-tropic virus has completed enrollment and p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Darunavir (darunavir)
• Maraviroc (maraviroc)
• Ritonavir (Ritonavir)

Snippet

Sponsor: Northwestern University | Conditions: HIV-1 Infection, HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2014-08-19